Orchid Pharma Limited

NSE:ORCHPHARMA.NS

1479.85 (INR) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320112010200920082007200620052004
Operating Activities:
Net Income 921.665463.182-19.512-1,165.3-1,310.701694.079-3,989.628-4,522.759-2,961.848-1,311.019-3,720.182754.3631,715.6514,698.347-338.1652,285.65925.566650.103199.838
Depreciation & Amortization 332.371547.868870.2461,089.1641,259.2111,299.4341,333.1291,410.1581,452.6652,163.8981,679.4861,537.3651,335.041,548.9961,339.9251,006.784850.893858.174637.813
Deferred Income Tax 0000000000-46.77100000000
Stock Based Compensation 00000000004.72500000000
Change In Working Capital -78.378-790.621595.657-369.595618.851-1,104.429-383.1251,871.702181.879-2,369.93542.0463,568.23272.3561,190.722-1,172.562-1,184.223-1,867.926-2,395.201-754.075
Accounts Receivables 196.467-416.535-229.194-820.248440.11-91.498451.381,053.726-514.25-4,065.344-1,041.19500000000
Inventory -354.881-560.81725.369-334.985140.628239.661175.131305.978100.7891,695.411,083.241-511.003-1,949.863,456.146-1,190.993-375.409-1,634.639-475.859-1,130.774
Accounts Payables 548.513139.141473.627179.30576.919-576.765-824.601425.116595.340000000000
Other Working Capital -468.47747.59325.855606.333-38.806-675.827-558.2561,565.72481.09004,079.2352,022.216-2,265.42418.431-808.814-233.287-1,919.342376.699
Other Non Cash Items 315.377-34.6-521.645681.591240.669-768.843,131.4294,410.9773,449.264-943.4163,115.0481,510.239198.248-7,781.235629.817-5.3161,027.58869.527787.344
Operating Cash Flow 1,216.392185.829924.746235.86808.03120.24491.8053,170.0782,121.96-2,460.4711,121.1237,370.1993,321.295-343.17459.0152,102.895936.113-17.397870.92
Investing Activities:
Investments In Property Plant And Equipment -648.148-849.131-144.035-6.04-42.424-66.266-62.104-85.106-14.663-557.845-7,439.866-2,940.446-3,867.14-2,246.897-4,813.203-5,456.049-4,779.545-1,841.163-2,689.26
Acquisitions Net 0576.11,139.0812.8640-372.2990.5830.0770000016,374.25500000
Purchases Of Investments -2,592.155-53.073-128.446-130.790-0.017-339.737-1.50000000-7.28200-1.205
Sales Maturities Of Investments 0-525.476128.446799.311,471.794372.316000000000000.150.275
Other Investing Activites -2,472.138536.992134.3166.707241.751520.997-218.4560.7250.1039,448.889866.2529.958193.0320.24143.5089.37.44412.43934.728
Investing Cash Flow -3,240.303-314.5881,129.362672.0511,671.121454.731-280.56-85.881-14.568,891.044-6,573.614-2,930.488-3,674.10814,127.599-4,769.695-5,454.031-4,772.101-1,828.574-2,655.462
Financing Activities:
Debt Repayment -2,085.47-1,098.063-2,047.852-1,250.8-10,441.0320-377.109-1,474.052-435.09900-3,009.099-3,370.47-14,130.934-3,944.784-3,316.409-10,743.211-4,308.364-2,348.547
Common Stock Issued 3,919.421000400000184.345000001,095.1546.78810.024799.69373.804
Common Stock Repurchased 000000000000007,954.3408,194.5062,501.8590
Dividends Paid 00000000000-249.016-818.009-82.414-230.631-231.046-225.126-155.676-146.123
Other Financing Activities 3,755.8761,409.727-120.129-399.0877,537.687-2.996333.903-2,188.906-2,612.895-3,982.9634,429.2-1,543.343,410.9443,445.296-563.2386,014.37,615.952,981.9853,890.004
Financing Cash Flow 1,833.949311.664-2,167.981-1,649.887-2,503.345-2.996333.903-3,662.958-2,863.649-3,982.9634,429.2-4,801.455-777.535-10,768.0524,310.8412,473.6334,852.1431,819.4941,769.138
Other Information:
Effect Of Forex Changes On Cash 000000000000000.0020000
Net Change In Cash 2,399.535182.905-113.873-741.976-24.194571.979145.148-578.761-756.2492,447.611-1,023.291-361.744-1,130.3483,016.3770.163-877.5031,016.155-26.477-15.404
Cash At End Of Period 2,665.651225.97143.066156.939898.915923.109351.132,570.643,149.4012,447.611-1,023.2911,769.172,130.9143,261.262244.884244.7211,098.13681.981108.458